Kamada VP discloses stock option holdings

Kamada Ltd executive Boris Gorelik filed an initial statement of beneficial ownership, reporting stock option holdings rather than new trades.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kamada Ltd executive Boris Gorelik filed an initial statement of beneficial ownership, reporting stock option holdings rather than new trades. The filing lists several grants of options to purchase Ordinary Shares, including tranches for 3,750 underlying shares at an exercise price of $9.4300 per share expiring on February 11, 2027, and 15,000 underlying shares at $5.0400 per share expiring on January 16, 2029. Additional option grants cover 15,000 underlying shares at an exercise price of $7.1400 per share expiring on October 22, 2035. The options are exercisable using a net-exercise method, and all exercise prices shown in the filing are convenience translations from New Israeli Shekels into U.S. dollars based on the Bank of Israel’s representative exchange rate as of March 13, 2026.

Insider Trade Summary

12 transactions reported

Mixed 12 txns

Insider Gorelik Boris

Role VP, BD and Strategic Programs

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 135,000 contracts (Direct)

Footnotes (2)

F1. These options to purchase ordinary shares are exercisable using a net-exercise method
F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Kamada (KMDA) executive Boris Gorelik show?

The Form 3 shows Boris Gorelik’s existing holdings of options to purchase Kamada Ordinary Shares. It details multiple option grants with specified exercise prices, expiration dates, and underlying share amounts, without reporting any new purchases, sales, or exercises of the company’s stock.

How many Kamada (KMDA) shares are covered by Boris Gorelik’s reported stock options?

The filing lists several option grants, including blocks for 3,750 underlying Ordinary Shares at an exercise price of $9.4300 and multiple 15,000-share blocks at $5.0400 and $7.1400. Each block has its own expiration date, indicating separate tranches of Kamada equity compensation.

What are the key exercise prices and expirations in the Kamada (KMDA) Form 3 options?

Reported options include exercise prices of $9.4300 expiring on February 11, 2027, $5.0400 expiring on January 16, 2029, and $7.1400 expiring on October 22, 2035. These figures apply to Ordinary Share options held directly by executive Boris Gorelik.

How are the exercise prices in the Kamada (KMDA) Form 3 translated into U.S. dollars?

All option exercise prices are presented in U.S. dollars as a convenience translation from New Israeli Shekels. The translation uses the Bank of Israel’s representative exchange rate as of March 13, 2026, as explicitly stated in the filing’s footnotes.

What does net-exercise mean for Boris Gorelik’s Kamada (KMDA) stock options?

The filing states that Gorelik’s options are exercisable using a net-exercise method. This means, instead of paying cash for the full exercise price, a portion of the underlying shares can be withheld to cover the cost, resulting in fewer shares delivered upon exercise.

Is the Kamada (KMDA) Form 3 for Boris Gorelik a buy or sell signal?

The Form 3 does not report any buying or selling activity. It simply discloses Boris Gorelik’s existing option holdings in Kamada, including terms such as exercise prices and expirations, providing a baseline view of his equity-based compensation position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/16/2026 - 07:10 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gorelik Boris

(Last)

(First)

(Middle)

208 HICKORY AVE

(Street)

TENAFLY

07670

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, BD and Strategic Programs

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Ordinary Shares⁽¹⁾	08/11/2021	02/11/2027	Ordinary Shares	3,750	$9.43⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	08/11/2022	02/11/2027	Ordinary Shares	3,750	$9.43⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	07/16/2023	01/16/2029	Ordinary Shares	15,000	$5.04⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	08/11/2023	02/11/2027	Ordinary Shares	3,750	$9.43⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	07/16/2024	01/16/2029	Ordinary Shares	15,000	$5.04⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	08/11/2024	02/11/2027	Ordinary Shares	3,750	$9.43⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	07/16/2025	01/16/2029	Ordinary Shares	15,000	$5.04⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	07/16/2026	01/16/2029	Ordinary Shares	15,000	$5.04⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2026	10/22/2035	Ordinary Shares	15,000	$7.14⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2027	10/22/2035	Ordinary Shares	15,000	$7.14⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2028	10/22/2035	Ordinary Shares	15,000	$7.14⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2029	10/22/2035	Ordinary Shares	15,000	$7.14⁽²⁾	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Boris Gorelik	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Kamada VP discloses stock option holdings

Rhea-AI Filing Summary

Positive

Negative